Hjem › Diffus sclerodermi › Michigan › Ann Arbor
Diffus sclerodermi kliniske forsøg i Ann Arbor, MI
7 studier for Diffus sclerodermi søger deltagere på steder i og omkring Ann Arbor (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
RekruttererFase 2
- Uni Of Michigan Health System, Ann Arbor
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RekruttererFase 2/3
- GSK Investigational Site, Ann Arbor
Platform Clinical Study for Conquering Scleroderma
RekruttererFase 2
- University of Michigan, Ann Arbor
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RekruttererFase 2/3
- University of Michigan, Ann Arbor
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
RekruttererFase 1/2
- Nkarta Investigational Site, Ann Arbor
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
RekruttererFase 2
- Galderma Investigational Site # 8743, Ann Arbor
The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
Rekrutterer
- University of Michigan, Ann Arbor
Diffus sclerodermi forsøg i andre byer
- New York City, NY8 studier
- Chicago, IL7 studier
- Durham, NC6 studier
- Los Angeles, CA6 studier
- Houston, TX5 studier
- Boston, MA5 studier
- Baltimore, MD5 studier
- Pittsburgh, PA4 studier
- New Orleans, LA4 studier
- Kansas City, KS4 studier
- Philadelphia, PA4 studier
- Charlotte, NC3 studier
Andre studier i Ann Arbor
- Prostatakræft27 studier
- Brystkræft26 studier
- Ikke-småcellet lungecancer26 studier
- Kræft (alle typer)25 studier
- Colorektal kræft23 studier
- Lungecancer23 studier
- Hjertesvigt22 studier
- Akut myeloid leukæmi17 studier
- Kardiovaskulær sygdom16 studier
- Bugspytkirtelkræft14 studier
- Melanom12 studier
- Nyrekancer (renocellulært karcinom)12 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.